PTTG1 and breast cancer: Future investigations should rigorously characterize disparities in the pathobiological role of securin across geographically diverse populations and molecular subtypes of BC, with particular attention to variations in genetic backgrounds, environmental exposures, and healthcare disparities that may influence its oncogenic functions, therapeutic responses, and prognostic significance.